Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2, 2004
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Adenocarcinoma (MeSH)
- Adult (MeSH)
- Aged (MeSH)
- Anti-Ulcer Agents (MeSH)
- Aspirin (MeSH)
- Barrett Esophagus (MeSH)
- Cost-Benefit Analysis (MeSH)
- Drug Administration Schedule (MeSH)
- Drug Costs (MeSH)
- Drug Therapy, Combination (MeSH)
- Esophageal Neoplasms (MeSH)
- Evidence-Based Medicine (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Omeprazole (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Prospective Studies (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Survival Rate (MeSH)
- United Kingdom (MeSH)